Safety, Tolerability and Pharmacokinetic Profile of TPT0301 in Healthy Volunteers
This very early study is exploring a new medicine named TPT0301, which is being developed to help people who experience nerve pain. This is the first time this particular medicine is being given to human volunteers. The main goals are to check if TPT0301 is safe for people to take and to understand how their bodies react to it. This includes looking at any side effects and how the medicine is absorbed, used, and removed by the body. This type of study, often called a Phase I trial, is a crucial step in developing new medicines, as it helps researchers decide if it's safe to continue testing in larger groups of people. It’s important because it could eventually lead to new ways to manage nerve pain.
At a glance
What is this study about?
This study is a very early step in developing a new medicine called TPT0301. It's designed for people who suffer from nerve pain, which can be a difficult condition to manage. When a new medicine is created, it goes through several stages of testing. This particular study is known as a 'Phase I' trial, which means it's the first time the medicine is being given to humans.
The main purpose of this study is to carefully check if TPT0301 is safe for people. The researchers will be looking closely for any side effects and how well people's bodies tolerate the medicine. They also want to understand what the body does to the medicine – how it's absorbed, how it travels around, and how it eventually leaves the body. This information helps them figure out the right doses for future, larger studies.
It's an important study because finding new and effective treatments for nerve pain could make a big difference to many people's lives. By taking part, volunteers are helping scientists learn vital information that could lead to new ways to help manage this challenging type of pain.
Key takeaways
- This is a very early study of a new medicine for nerve pain.
- It's the first time this medicine is being given to people.
- The main goals are to check for safety and how the body handles the medicine.
- Participants must be 18 years or older, with no upper age limit.
- Taking part helps medical science and could lead to new treatments.
- You can withdraw from the study at any time without affecting your normal care.
Who may be eligible?
This study is open to both men and women who are at least 18 years old. You don't have an upper age limit to take part, so older adults are welcome too.
Because this is an early study, participants will likely need to be generally healthy. This helps researchers focus on the new medicine's effects without other health issues making it complicated. Specific health checks will be done to make sure it's safe for you to join.
The research team will carry out a full assessment to find out if you meet all the necessary requirements to participate. They will be able to tell you if this study is suitable for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you generally healthy, or do you have well-managed underlying health conditions?
- Are you able to attend appointments at the clinic regularly?
- Are you comfortable potentially staying overnight at the clinic for some visits?
- Are you willing to follow study instructions carefully?
What does participation involve?
If you decide to take part, you'll be given the new medicine, TPT0301. This study will involve several visits to the clinic, possibly including stays for a few days at a time. During these visits, the research team will regularly check on your health. This will involve things like blood tests, urine tests, checking your heart rate and blood pressure, and asking you about how you're feeling. They'll want to know if you experience any side effects. You'll have regular follow-up appointments to make sure everything is okay after you've taken the medicine. The total length of your participation will depend on the specific schedule, but these types of early studies usually happen over several weeks or months.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What is nerve pain?
Nerve pain, also called neuropathic pain, happens when nerves are damaged or not working properly. It can feel like burning, shooting, stabbing, or tingling sensations.
What does 'Phase I' mean?
Phase I is the first step where a new medicine is given to humans. It's mainly to check if it's safe and how the body handles it.
Will this medicine cure my nerve pain?
This early study isn't designed to cure nerve pain. It's to see if the medicine is safe enough to study further. Any benefits to your pain would be a bonus at this stage.
Who is paying for this research?
Clinical trials are usually funded by the company developing the medicine, or sometimes by government or research organisations. The study team can tell you who is funding this specific trial.
Will I be paid for taking part?
Sometimes volunteers receive a payment for their time and travel expenses. This will be clearly explained by the research team before you agree to take part.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.